Vilin Bio Med Limited
ListedSMEPharmaceuticals & Healthcare · NSE
Incorporated in 2005, Vilin Bio Med Limited is engaged in the domestic manufacturing of pharmaceutical products, supplying in bulk to pharmaceutical manufacturers, marketers, and traders who distribute them to end customers. The company’s product range includes Oral Liquids (Syrups, Suspensions, Dry Powders – both βeta and Non-βeta-Lactam), Tablets and Capsules (βeta and Non-βeta-Lactam), External Preparations, and Dry Powders. Vilin Bio Med operates its R&D center and manufacturing facility in Roorkee, Uttarakhand, ensuring quality and innovation in production. The company reported revenue of ₹1,121.91 lakhs in FY2022 and ₹1,171.88 lakhs in FY2021.
Price Band
₹30
Issue Size
₹12.00 Cr
Lot Size
4000 shares
GMP
—
Est. Listing
₹30
at current GMP
Subscribed
2.82x
overall
Open
16 Jun 2023
Close
21 Jun 2023
Allotment
26 Jun 2023
Refund
27 Jun 2023
Demat Credit
28 Jun 2023
Listing
30 Jun 2023
Last updated 12 days ago
Overall Subscription
2.82x
Total Demand
QIB Multiplier
0.00x
Institutions & Funds
NII / HNI
1.48x
High Net-Worth
Retail (RII)
4.02x
Individual Bidders
Category-Wise Subscription Breakup
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| NIB | 1,792,000 | 2,644,000 | 1.48x |
| RETAIL | 2,000,000 | 8,040,000 | 4.02x |
| Total | 3,792,000 | 10,684,000 | 2.82x |
Application-Wise Breakup
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| Retail (RII) | 350 | 1,407 | 4.02x |
| HNIs (10L +) | 2 | 3 | 1.48x |
| HNIs (2-10L) | 11 | 16 | 1.48x |
| Total Applications | 363 | 1,426 | 3.93x |
Day-Wise Subscription Progress
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.
About Vilin Bio Med Limited Public Issue & Market Profile
Vilin Bio Med Limited is bringing an initial public offering (IPO) in the Pharmaceuticals & Healthcare sector with an aggregate issue size of ₹12 Crores. The shares are offered at a price band of ₹30 to ₹30 per equity share on NSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.
Bidding & Quota Instructions:
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Allotment Reconciliation Schedule:
Following the close of bidding on 2023-06-21, the basis of allotment is scheduled to be finalized on 2023-06-26. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Bigshare Services Private Limited) or the BSE allotment checking window.
Frequently Asked Questions
What is Vilin Bio Med Limited IPO GMP today?
Currently, Vilin Bio Med Limited IPO Grey Market Premium (GMP) is not actively quoted or is quoted flat at ₹0. The shares are expected to list close to the issue price band of ₹30 to ₹30 per equity share.
What is the expected profit per lot for Vilin Bio Med Limited IPO?
The retail lot size is 4000 shares requiring a minimum application amount of ₹1,20,000. Expected listing price is ₹30 per equity share.
What is the issue size and price band for Vilin Bio Med Limited IPO?
The Vilin Bio Med Limited IPO aggregate issue size is ₹12 Crores with an equity price band set at ₹30 to ₹30 per equity share. The retail lot size is 4000 shares requiring a minimum capital outlay of approx. ₹1,20,000.
How can I check Vilin Bio Med Limited IPO live subscription demand?
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 2.82x (Retail: 4.02x, QIB: 0.00x, NII: 1.48x). You can track live multiples directly on our dedicated subscription page.
Where and when will Vilin Bio Med Limited IPO allotment status be published?
The basis of allotment will be published on the official registrar portal (Bigshare Services Private Limited) and the BSE status verification website on or around 2023-06-26. Investors can verify status using PAN card or application number.
When is the listing date for Vilin Bio Med Limited IPO?
Vilin Bio Med Limited shares are scheduled to list on NSE on 2023-06-30.